Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/1471-2172-7-11.

Title:
VACUTAINER® CPT™ and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples | BMC Immunology
Description:
Background For immune monitoring studies during HIV vaccine clinical trials, whole blood specimens from HIV seropositive (HIV+) patients may be collected at multiple sites and sent to a central location for peripheral blood mononuclear cell (PBMC) isolation, cryopreservation and functional evaluation. In this study we show a comparison of two PBMC preparation options, Ficoll density gradient separation (Ficoll) and Cell Preparation Tubes (CPT) using shipped whole blood specimens from 19 HIV+ patients (CD4 > 350, viral load < 50). The pre- and post- cryopreservation performance of samples collected by these two methods were compared by assessment of antigen-specific IFNγ expression in CD8+ and CD8- T cells, cellular viability, and cellular recovery. Results The results indicate that cryopreserved PBMC samples tested for CMV- and HIV- specific interferon-gamma (IFNγ) expression performed equivalent to the respective fresh PBMC processed under both collection conditions. Compared to fresh PBMC, the viability was significantly lower for cryopreserved PBMC derived using Ficoll, although it was never less than 90%. There were no significant differences in the IFNγ response, viability, or recovery between cryopreserved PBMC derived by Ficoll and by CPT. Conclusion These data suggest that CPT is an efficient system for the collection and cryopreservation of functionally active HIV+ PBMC, as well as a viable alternative to Ficoll gradient separation.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

pbmc, samples, cells, fresh, viability, cryopreserved, blood, cryopreservation, processing, cpt, cell, pubmed, article, study, methods, ficoll, figure, hiv, method, functional, central, recovery, significant, assays, sample, google, scholar, data, processed, collection, cytokine, response, responses, cptprocessed, collected, ficollprocessed, cas, analysis, flow, viable, donors, peptide, immunol, authors, number, ifnγ, significantly, cytometry, frozen, staining,

Topics {✒️}

paired t-test antigen-specific memory/effector cd4+ hiv-p55 peptide mix hiv-p55 peptide mixes cell preparation tube evacuation type/vacutainer® tubes hiv- specific interferon-gamma cmv-pp65 peptide mix cmv-pp65 peptide mix cell preparation tubes article download pdf multicenter clinical trials polypropylene v-bottom plate assessing antigen-specific responses labor-intensive process requiring cryopreserved mononuclear cells antigen-specific homeostatic mechanism cytokine flow cytometry cpt-processing routinely yields clinical trials antigen-specific ifnγ expression single-cell assays cell subsets cell cytokine expression diminished cell numbers ficoll-processed cryopreserved pbmc ficoll gradient separation flow cytometry data antigen-specific lymphocyte function full access cryopreserved ficoll-processed samples cpt-processed pbmc demonstrated privacy choices/manage cookies article-processing charge cryopreserved cpt-processed samples authors’ original file cmvpp65 peptide mix hivp55 peptide mix hiv-infected patients cell separation ficoll-processed fresh pbmc median post-thaw recovery fresh ficoll-processed samples cpt-processed fresh pbmc 19 hiv-seropositive donors pbmc preparation options clinical researchers prefer immune monitoring studies pre-determined time points cell responses

Schema {🗺️}

WebPage:
      mainEntity:
         headline:VACUTAINER® CPT™ and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples
         description:For immune monitoring studies during HIV vaccine clinical trials, whole blood specimens from HIV seropositive (HIV+) patients may be collected at multiple sites and sent to a central location for peripheral blood mononuclear cell (PBMC) isolation, cryopreservation and functional evaluation. In this study we show a comparison of two PBMC preparation options, Ficoll density gradient separation (Ficoll) and Cell Preparation Tubes (CPT) using shipped whole blood specimens from 19 HIV+ patients (CD4 &gt; 350, viral load &lt; 50). The pre- and post- cryopreservation performance of samples collected by these two methods were compared by assessment of antigen-specific IFNγ expression in CD8+ and CD8- T cells, cellular viability, and cellular recovery. The results indicate that cryopreserved PBMC samples tested for CMV- and HIV- specific interferon-gamma (IFNγ) expression performed equivalent to the respective fresh PBMC processed under both collection conditions. Compared to fresh PBMC, the viability was significantly lower for cryopreserved PBMC derived using Ficoll, although it was never less than 90%. There were no significant differences in the IFNγ response, viability, or recovery between cryopreserved PBMC derived by Ficoll and by CPT. These data suggest that CPT is an efficient system for the collection and cryopreservation of functionally active HIV+ PBMC, as well as a viable alternative to Ficoll gradient separation.
         datePublished:2006-05-25T00:00:00Z
         dateModified:2006-05-25T00:00:00Z
         pageStart:1
         pageEnd:8
         license:http://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1471-2172-7-11
         keywords:
            Peripheral Blood Mononuclear Cell
            Good Viability
            Peripheral Blood Mononuclear Cell Sample
            Cryopreserved Sample
            Cell Preparation Tube
            Immunology
            Allergology
            Vaccine
            Cytokines and Growth Factors
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2172-7-11/MediaObjects/12865_2006_Article_96_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2172-7-11/MediaObjects/12865_2006_Article_96_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2172-7-11/MediaObjects/12865_2006_Article_96_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2172-7-11/MediaObjects/12865_2006_Article_96_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2172-7-11/MediaObjects/12865_2006_Article_96_Fig5_HTML.jpg
         isPartOf:
            name:BMC Immunology
            issn:
               1471-2172
            volumeNumber:7
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Joyce J Ruitenberg
               affiliation:
                     name:BD Biosciences
                     address:
                        name:BD Biosciences, San Jose, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Candice B Mulder
               affiliation:
                     name:RUSH University Medical Center
                     address:
                        name:RUSH University Medical Center, Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Vernon C Maino
               affiliation:
                     name:BD Biosciences
                     address:
                        name:BD Biosciences, San Jose, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alan L Landay
               affiliation:
                     name:RUSH University Medical Center
                     address:
                        name:RUSH University Medical Center, Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Smita A Ghanekar
               affiliation:
                     name:BD Biosciences
                     address:
                        name:BD Biosciences, San Jose, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:VACUTAINER® CPT™ and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples
      description:For immune monitoring studies during HIV vaccine clinical trials, whole blood specimens from HIV seropositive (HIV+) patients may be collected at multiple sites and sent to a central location for peripheral blood mononuclear cell (PBMC) isolation, cryopreservation and functional evaluation. In this study we show a comparison of two PBMC preparation options, Ficoll density gradient separation (Ficoll) and Cell Preparation Tubes (CPT) using shipped whole blood specimens from 19 HIV+ patients (CD4 &gt; 350, viral load &lt; 50). The pre- and post- cryopreservation performance of samples collected by these two methods were compared by assessment of antigen-specific IFNγ expression in CD8+ and CD8- T cells, cellular viability, and cellular recovery. The results indicate that cryopreserved PBMC samples tested for CMV- and HIV- specific interferon-gamma (IFNγ) expression performed equivalent to the respective fresh PBMC processed under both collection conditions. Compared to fresh PBMC, the viability was significantly lower for cryopreserved PBMC derived using Ficoll, although it was never less than 90%. There were no significant differences in the IFNγ response, viability, or recovery between cryopreserved PBMC derived by Ficoll and by CPT. These data suggest that CPT is an efficient system for the collection and cryopreservation of functionally active HIV+ PBMC, as well as a viable alternative to Ficoll gradient separation.
      datePublished:2006-05-25T00:00:00Z
      dateModified:2006-05-25T00:00:00Z
      pageStart:1
      pageEnd:8
      license:http://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1471-2172-7-11
      keywords:
         Peripheral Blood Mononuclear Cell
         Good Viability
         Peripheral Blood Mononuclear Cell Sample
         Cryopreserved Sample
         Cell Preparation Tube
         Immunology
         Allergology
         Vaccine
         Cytokines and Growth Factors
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2172-7-11/MediaObjects/12865_2006_Article_96_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2172-7-11/MediaObjects/12865_2006_Article_96_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2172-7-11/MediaObjects/12865_2006_Article_96_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2172-7-11/MediaObjects/12865_2006_Article_96_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2172-7-11/MediaObjects/12865_2006_Article_96_Fig5_HTML.jpg
      isPartOf:
         name:BMC Immunology
         issn:
            1471-2172
         volumeNumber:7
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Joyce J Ruitenberg
            affiliation:
                  name:BD Biosciences
                  address:
                     name:BD Biosciences, San Jose, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Candice B Mulder
            affiliation:
                  name:RUSH University Medical Center
                  address:
                     name:RUSH University Medical Center, Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Vernon C Maino
            affiliation:
                  name:BD Biosciences
                  address:
                     name:BD Biosciences, San Jose, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alan L Landay
            affiliation:
                  name:RUSH University Medical Center
                  address:
                     name:RUSH University Medical Center, Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Smita A Ghanekar
            affiliation:
                  name:BD Biosciences
                  address:
                     name:BD Biosciences, San Jose, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:BMC Immunology
      issn:
         1471-2172
      volumeNumber:7
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:BD Biosciences
      address:
         name:BD Biosciences, San Jose, USA
         type:PostalAddress
      name:RUSH University Medical Center
      address:
         name:RUSH University Medical Center, Chicago, USA
         type:PostalAddress
      name:BD Biosciences
      address:
         name:BD Biosciences, San Jose, USA
         type:PostalAddress
      name:RUSH University Medical Center
      address:
         name:RUSH University Medical Center, Chicago, USA
         type:PostalAddress
      name:BD Biosciences
      address:
         name:BD Biosciences, San Jose, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Joyce J Ruitenberg
      affiliation:
            name:BD Biosciences
            address:
               name:BD Biosciences, San Jose, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Candice B Mulder
      affiliation:
            name:RUSH University Medical Center
            address:
               name:RUSH University Medical Center, Chicago, USA
               type:PostalAddress
            type:Organization
      name:Vernon C Maino
      affiliation:
            name:BD Biosciences
            address:
               name:BD Biosciences, San Jose, USA
               type:PostalAddress
            type:Organization
      name:Alan L Landay
      affiliation:
            name:RUSH University Medical Center
            address:
               name:RUSH University Medical Center, Chicago, USA
               type:PostalAddress
            type:Organization
      name:Smita A Ghanekar
      affiliation:
            name:BD Biosciences
            address:
               name:BD Biosciences, San Jose, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:BD Biosciences, San Jose, USA
      name:RUSH University Medical Center, Chicago, USA
      name:BD Biosciences, San Jose, USA
      name:RUSH University Medical Center, Chicago, USA
      name:BD Biosciences, San Jose, USA

External Links {🔗}(95)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

3.96s.